# User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity

> **NCT01036646** · — · COMPLETED · sponsor: **Abbott RDx Cardiometabolic** · enrollment: 183 (actual)

## Conditions studied

- Oral Anticoagulation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01036646
- **Lead sponsor:** Abbott RDx Cardiometabolic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-06
- **Final completion:** 2010-09
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2013-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01036646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01036646, "User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01036646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*